Loss-of-function somatic mutations in TET2 are strongly associated with hematological malignancies, including myeloid, T- and B-cell malignancies and chronic lymphoproliferative disorders of NK cells (CLPD-NK)32–34. The gene discussed is TET2; the disease is hematologic disorder.